Validation of Deep Learning–based Augmentation for Reduced ¹⁸F-FDG Dose for PET/MRI in Children and Young Adults with Lymphoma

Abstract

CNN enhancement of PET/MRI scans may enable 50% ¹⁸F-FDG dose reduction with correct treatment response assessment of children and young adults with lymphoma.<b>Keywords:</b> Pediatrics, PET/MRI, Computer Applications Detection/Diagnosis, Lymphoma, Tumor Response, Whole-Body Imaging, Technology AssessmentClinical trial registration no: NCT01542879 <i>Supplemental material is available for this article.</i> © RSNA, 2021.